Cancer Risk Associated with Lorcaserin — The FDA’s...

New England Journal of Medicine 2020 / 09 Vol. 383; Iss. 11

Cancer Risk Associated with Lorcaserin — The FDA’s Review of the CAMELLIA-TIMI 61 Trial

Sharretts, John, Galescu, Ovidiu, Gomatam, Shanti, Andraca-Carrera, Eugenio, Hampp, Christian, Yanoff, Lisa
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
383
Journal:
New England Journal of Medicine
DOI:
10.1056/NEJMp2003873
Date:
September, 2020
File:
PDF, 359 KB
2020
Conversion to is in progress
Conversion to is failed